Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
7919 | 1236 | 42.3 | 88% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | STEATOSIS | Author keyword | 16 | 11% | 11% | 137 |
2 | HEPATOGENOUS DIABETES | Author keyword | 10 | 73% | 1% | 8 |
3 | DIPARTIMENTO MED GASTROENTEROL ALMA MATER STUDI | Address | 2 | 67% | 0% | 2 |
4 | HEPATITIS C CORE PROTEIN | Author keyword | 2 | 67% | 0% | 2 |
5 | IMMUNOL HISTOCOMBATIBIL | Address | 2 | 67% | 0% | 2 |
6 | POST COURSE MED HLTH | Address | 2 | 67% | 0% | 2 |
7 | VIROPATHOL UNIT | Address | 2 | 67% | 0% | 2 |
8 | CATTEDRA UNITA OPERAT GASTROENTEROL | Address | 2 | 29% | 0% | 5 |
9 | HEPATOCYTE STEATOSIS | Author keyword | 2 | 43% | 0% | 3 |
10 | UNIT CLIN MANAGEMENT DIGEST DIS | Address | 2 | 19% | 1% | 7 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | STEATOSIS | 31 | 12% | 20% | 244 |
2 | VIRUS CORE PROTEIN | 21 | 24% | 6% | 79 |
3 | FIBROSIS PROGRESSION | 17 | 15% | 8% | 104 |
4 | VIRUS GENOTYPE 3 | 15 | 68% | 1% | 13 |
5 | HISTOPATHOLOGICAL MANIFESTATIONS | 15 | 77% | 1% | 10 |
6 | B C INFECTION | 12 | 86% | 0% | 6 |
7 | HEPATOCYTE STEATOSIS | 12 | 86% | 0% | 6 |
8 | SERUM LIPID PEROXIDATION | 12 | 86% | 0% | 6 |
9 | GLUCOSE ABNORMALITIES | 11 | 65% | 1% | 11 |
10 | PEGINTERFERON PLUS RIBAVIRIN | 11 | 39% | 2% | 22 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
Hepatitis B virus infection and metabolic syndrome: Fact or fiction? | 2015 | 2 | 49 | 61% |
Is Genotype 3 of the Hepatitis C Virus the New Villain? | 2014 | 15 | 66 | 36% |
Hepatic steatosis in hepatitis B virus infected patients: Meta-analysis of risk factors and comparison with hepatitis C infected patients | 2011 | 28 | 42 | 67% |
Hepatitis C virus diversity and hepatic steatosis | 2013 | 13 | 61 | 61% |
Hepatitis C and lipid metabolism, hepatic steatosis, and NAFLD: still important in the era of direct acting antiviral therapy? | 2014 | 7 | 70 | 61% |
Steatosis in chronic hepatitis C: Why does it really matter? | 2006 | 208 | 71 | 49% |
Metabolic alterations and chronic hepatitis C: treatment strategies | 2011 | 18 | 99 | 73% |
Obesity Affects the Liver - The Link between Adipocytes and Hepatocytes | 2011 | 60 | 96 | 26% |
Hepatic steatosis and hepatitis C: Still unhappy bedfellows? | 2011 | 18 | 78 | 65% |
Liver cirrhosis and diabetes: Risk factors, pathophysiology, clinical implications and management | 2009 | 70 | 71 | 38% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | DIPARTIMENTO MED GASTROENTEROL ALMA MATER STUDI | 2 | 67% | 0.2% | 2 |
2 | IMMUNOL HISTOCOMBATIBIL | 2 | 67% | 0.2% | 2 |
3 | POST COURSE MED HLTH | 2 | 67% | 0.2% | 2 |
4 | VIROPATHOL UNIT | 2 | 67% | 0.2% | 2 |
5 | CATTEDRA UNITA OPERAT GASTROENTEROL | 2 | 29% | 0.4% | 5 |
6 | UNIT CLIN MANAGEMENT DIGEST DIS | 2 | 19% | 0.6% | 7 |
7 | ASL CASERTA | 1 | 100% | 0.2% | 2 |
8 | DIPARTIMENTO SCI PROMOZ SALUTE GD ALESSANDRO | 1 | 50% | 0.2% | 2 |
9 | EQUIPE MIXTE INSERM 0114 | 1 | 100% | 0.2% | 2 |
10 | INTERNAL MED CLIN HOSP MARCIANISE | 1 | 100% | 0.2% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000131991 | STUDY HEPATITIS C//U748//VIROL INFECT DIS |
2 | 0.0000126872 | ADIPONUTRIN//PNPLA3//PATATIN LIKE PHOSPHOLIPASE DOMAIN CONTAINING 3 |
3 | 0.0000106349 | TELAPREVIR//RIBAVIRIN//BOCEPREVIR |
4 | 0.0000093876 | CHIRURG D//ALCOHOLIC LIVER DISEASE ALD//CHRONIC HEPATITIS INDUCED BY ALCOHOL |
5 | 0.0000090076 | NON ALCOHOLIC FATTY LIVER DISEASE//NON ALCOHOLIC STEATOHEPATITIS//NASH |
6 | 0.0000072766 | POST TRANSPLANT DIABETES MELLITUS//NODAT//NEW ONSET DIABETES AFTER TRANSPLANTATION |
7 | 0.0000072153 | CHRONIC HEPATITIS C//INTERFERON THERAPY//HCV RNA |
8 | 0.0000069914 | LATE EVENING SNACK//NON PROTEIN RESPIRATORY QUOTIENT//BRANCHED CHAIN AMINO ACIDS |
9 | 0.0000059298 | TRANSIENT ELASTOGRAPHY//LIVER STIFFNESS//FIBROSCAN |
10 | 0.0000057906 | HEPATITIS A E//ESKIMOS//ARCTIC MEDICINE |